Top

Published in:

01-06-2015 | Research Article

GC-MS-based plasma metabolomic investigations of morphine dependent rats at different states of euphoria, tolerance and naloxone-precipitated withdrawal

Authors: Ruoxu Liu, Jianhua Cheng, Jingwen Yang, Xinghua Ding, Shuguang Yang, Fangting Dong, Ning Guo, Shaojun Liu

Published in: Metabolic Brain Disease | Issue 3/2015

Abstract

Long-term or excessive application of morphine leads to tolerance and addiction, which hindered its conventional applications as a drug. Although tremendous progress has been made on the mechanisms of morphine, crucial evidence elaborating the neurobiological basis of tolerance and dependence is still lacking. To further explore the physiological adaptions during morphine’s application, a systematic screening of small molecules in blood has been carried out. The plasma of morphine dependent rats was collected at different time points with or without naloxone treatment, and was analyzed by gas chromatography-mass spectrometry (GC-MS). Partial least squares discriminate analysis (PLS-DA) and the Student’s t Tests with the false discovery rate (FDR) correction were conducted on the normalized data for the distinction of groups and the identification of the most contributed metabolites. Clear separation is observed between different treatments, and 29 out of 41 metabolites changes significantly compared with the corresponding controls. The concentration of threonine, glycine, serine, beta-d-glucose and oxalic acid are consistently changed in all morphine treated groups compared with controls. Through this experiment we find characteristic metabolites in different dependent states and discuss the possible compensation effects. The interpretation of these metabolites would throw light on the biological effects of morphine and reveal the possibilities to become marker of morphine addiction.

Arvelo MB, Cooper JT, Longo C, Daniel S, Grey ST, Mahiou J, Czismadia E, Abu-Jawdeh G, Ferran C (2002) A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology 35(3):535–543. doi:10.1053/jhep.2002.31309 CrossRefPubMed

Bagnol D, Mansour A, Akil H, Watson SJ (1997) Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract. Neuroscience 81(2):579–591CrossRefPubMed

Bailey CP, Connor M (2005) Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 5(1):60–68. doi:10.1016/j.coph.2004.08.012 CrossRefPubMed

Beyoglu D, Idle JR (2013) Metabolomics and its potential in drug development. Biochem Pharmacol 85(1):12–20. doi:10.1016/j.bcp.2012.08.013 CrossRefPubMed

Bh HAR (2013) TOMES(R) information system, vol Volume 158. Micromedex, Inc, Englewood

Bryant HU, Bernton EW, Holaday JW (1987) Immunosuppressive effects of chronic morphine treatment in mice. Life Sci 41(14):1731–1738CrossRefPubMed

Buydens-Branchey L, Branchey M (2003) Association between low plasma levels of cholesterol and relapse in cocaine addicts. Psychosom Med 65(1):86–91CrossRefPubMed

Chen Y, Mestek A, Liu J, Hurley JA, Yu L (1993) Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol 44(1):8–12PubMed

Corbett AD, Henderson G, McKnight AT, Paterson SJ (2006) 75 years of opioid research: the exciting but vain quest for the Holy Grail. Br J Pharmacol 147(Suppl 1):S153–S162. doi:10.1038/sj.bjp.0706435 PubMedCentralPubMed

Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH (1992) Cloning of a delta opioid receptor by functional expression. Science 258(5090):1952–1955CrossRefPubMed

Feng B, Wu S, Lv S, Liu F, Chen H, Yan X, Li Y, Dong F, Wei L (2007) Metabolic profiling analysis of a D-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure. J Proteome Res 6(6):2161–2167. doi:10.1021/pr0606326 CrossRefPubMed

Feng B, Wu S, Lv S, Fang J, Liu F, Li Y, Gao Y, Yan X, Dong F, Wei L (2008) Dynamic metabonomic analysis of BALB/c mice with different outcomes after D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc 14(11):1620–1631. doi:10.1002/lt.21578

Fiehn O, Kopka J, Dormann P, Altmann T, Trethewey RN, Willmitzer L (2000) Metabolite profiling for plant functional genomics. Nat Biotechnol 18(11):1157–1161. doi:10.1038/81137 CrossRefPubMed

Francis DL, Schneider C (1971) Jumping after naloxone precipitated withdrawal of chronic morphine in the rat. Br J Pharmacol 41(2):424P–425PPubMedCentralPubMed

Frenklakh L, Bhat RS, Bhaskaran M, Sharma S, Sharma M, Dinda A, Singhal PC (2006) Morphine-induced degradation of the host defense barrier role of intestinal mucosal injury. Dig Dis Sci 51(2):318–325. doi:10.1007/s10620-006-3132-0 CrossRefPubMed

Harari Y, Weisbrodt NW, Moody FG (2006) The effect of morphine on mast cell-mediated mucosal permeability. Surgery 139(1):54–60. doi:10.1016/j.surg.2005.07.009 CrossRefPubMed

Hedner T, Cassuto J (1987) Opioids and opioid receptors in peripheral tissues. Scand J Gastroenterol Suppl 130:27–46CrossRefPubMed

Henderson G, McKnight AT (1997) The orphan opioid receptor and its endogenous ligand–nociceptin/orphanin FQ. Trends Pharmacol Sci 18(8):293–300CrossRefPubMed

Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG (1992) The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci U S A 89(24):12048–12052CrossRefPubMedCentralPubMed

Kleszczewska E, Wiszowata A, Lisowski P (2005) Determination of ascorbic and dehydroascorbic acid concentration using HPLC method in smokers with stable coronary artery disease scheduled for coronary artery bypass grafting (CABG). Przegl Lek 62(10):1054–1057PubMed

Koek W, France CP, Javors MA (2012) Morphine-induced motor stimulation, motor incoordination, and hypothermia in adolescent and adult mice. Psychopharmacology 219(4):1027–1037. doi:10.1007/s00213-011-2432-z CrossRefPubMedCentralPubMed

Kornetsky C, Wheeling HS (1982) An animal model for opiate induced euphoria and analgesia. Ther Umschau Rev Therapeutique 39(8):617–623

Lorenzetti OJ, Sancilio LF (1970) Morphine dependent rats as a model for evaluating potential addiction liability of analgesic compounds. Arch Int Pharmacodyn Ther 183(2):391–402PubMed

Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, Pardo L, Weis WI, Kobilka BK, Granier S (2012) Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature 485(7398):321–326. doi:10.1038/nature10954 CrossRefPubMedCentralPubMed

Martini L, Whistler JL (2007) The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence. Curr Opin Neurobiol 17(5):556–564. doi:10.1016/j.conb.2007.10.004 CrossRefPubMed

Mei B, Wang T, Wang Y, Xia Z, Irwin MG, Wong GT (2013) High dose remifentanil increases myocardial oxidative stress and compromises remifentanil infarct-sparing effects in rats. Eur J Pharmacol. doi:10.1016/j.ejphar.2013.07.030 PubMed

Nishimura E, Buchan AM, McIntosh CH (1986) Autoradiographic localization of mu- and delta-type opioid receptors in the gastrointestinal tract of the rat and guinea pig. Gastroenterology 91(5):1084–1094PubMed

Olin M, Oh S, Roy S, Peterson P, Molitor T (2012) Morphine induces splenocyte trafficking into the CNS. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 7(2):436–443. doi:10.1007/s11481-011-9307-2 CrossRef

Peng X, Cebra JJ, Adler MW, Meissler JJ Jr, Cowan A, Feng P, Eisenstein TK (2001) Morphine inhibits mucosal antibody responses and TGF-beta mRNA in gut-associated lymphoid tissue following oral cholera toxin in mice. J Immunol 167(7):3677–3681CrossRefPubMed

Pinter-Kubler B, Ferenczi S, Nunez C, Zelei E, Polyak A, Milanes MV, Kovacs KJ (2013) Differential changes in expression of stress- and metabolic-related neuropeptides in the rat hypothalamus during morphine dependence and withdrawal. PLoS One 8(6):e67027. doi:10.1371/journal.pone.0067027 CrossRefPubMedCentralPubMed

Qiu Y, Wang Y, Law PY, Chen HZ, Loh HH (2011) Cholesterol regulates micro-opioid receptor-induced beta-arrestin 2 translocation to membrane lipid rafts. Mol Pharmacol 80(1):210–218. doi:10.1124/mol.110.070870 CrossRefPubMedCentralPubMed

Sternini C, Patierno S, Selmer IS, Kirchgessner A (2004) The opioid system in the gastrointestinal tract. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 16(Suppl 2):3–16. doi:10.1111/j.1743-3150.2004.00553.x CrossRef

Sun B, Wu S, Li L, Li H, Zhang Q, Chen H, Li F, Dong F, Yan X (2009) A metabolomic analysis of the toxicity of Aconitum sp. alkaloids in rats using gas chromatography/mass spectrometry. Rapid Commun Mass Spect: RCM 23(8):1221–1228. doi:10.1002/rcm.3992 CrossRef

Thomson/Micromedex (2007) Drug information for the health care professional. vol Volume 1. Greenwood Village CO

Tubaro E, Avico U, Santiangeli C, Zuccaro P, Cavallo G, Pacifici R, Croce C, Borelli G (1985) Morphine and methadone impact on human phagocytic physiology. Int J Immunopharmacol 7(6):865–874CrossRefPubMed

West JP, Lysle DT, Dykstra LA (1997) Tolerance development to morphine-induced alterations of immune status. Drug Alcohol Depend 46(3):147–157CrossRefPubMed

Williams JT, Christie MJ, Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81(1):299–343PubMed

Wold H (1966) Estimation of principal components and related models by iterative least squares. In: Multivariate analysis. Academic Press, pp 391–420. http://www.citeulike.org/user/konradkryba/article/8609111

Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, Mascarella SW, Westkaemper RB, Mosier PD, Roth BL, Cherezov V, Stevens RC (2012) Structure of the human kappa-opioid receptor in complex with JDTic. Nature 485(7398):327–332. doi:10.1038/nature10939 CrossRefPubMedCentralPubMed

Zarembski PM, Hodgkinson A (1967) Plasma oxalic acid and calcium levels in oxalate poisoning. J Clin Pathol 20(3):283–285CrossRefPubMedCentralPubMed

Zhang J, Zhang Y (2008) Neuropharmacology. People’s Medical Publishing House Co., Beijing

Zhu Y, Hsu MS, Pintar JE (1998) Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. J Neurosci Off J Soc Neurosci 18(7):2538–2549

Title: GC-MS-based plasma metabolomic investigations of morphine dependent rats at different states of euphoria, tolerance and naloxone-precipitated withdrawal
Authors: Ruoxu Liu
Jianhua Cheng
Jingwen Yang
Xinghua Ding
Shuguang Yang
Fangting Dong
Ning Guo
Shaojun Liu
Publication date: 01-06-2015
Publisher: Springer US
Published in: Metabolic Brain Disease / Issue 3/2015
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-014-9638-9

At a glance: The STEP trials

Springer Medicine

GC-MS-based plasma metabolomic investigations of morphine dependent rats at different states of euphoria, tolerance and naloxone-precipitated withdrawal

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2015

Electroacupuncture improves cognitive deficits associated with AMPK activation in SAMP8 mice

Near infrared radiation protects against oxygen-glucose deprivation-induced neurotoxicity by down-regulating neuronal nitric oxide synthase (nNOS) activity in vitro

Protective effects of alpha lipoic acid on high glucose-induced neurotoxicity in PC12 cells

Role of neurotrophin in the taste system following gustatory nerve injury

Using saccades to diagnose covert hepatic encephalopathy

Blueberry treatment decreased D-galactose-induced oxidative stress and brain damage in rats